{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T16:05:59Z","timestamp":1792944359703,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002744","name":"Bar-Ilan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002744","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Atypical endometrial hyperplasia (AEH) is a known precursor to endometrioid endometrial carcinoma. However, occult carcinoma may already be present at diagnosis, complicating surgical planning. Accurate preoperative risk stratification is crucial, especially for guiding the selective use of sentinel lymph node biopsy. This study aimed to identify predictors of occult carcinoma and develop a model to estimate the risk of malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective case\u2013control study of 101 women diagnosed with AEH who underwent hysterectomy between 2010 and 2024 at Galilee Medical Center. Clinical, metabolic, and imaging data were extracted. Patients were stratified based on the final pathology into two groups: those with occult carcinoma and those with AEH only. Multivariable logistic regression was employed to identify independent predictors and construct a predictive model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Occult endometrial carcinoma was identified in 37 women (36.6%). Women with occult endometrial carcinoma were older and more likely to present with postmenopausal bleeding. Occult carcinoma was more frequently detected after Pipelle biopsy than after hysteroscopy or dilation and curettage (43.2% vs. 17.2%). In multivariable analysis, Pipelle biopsy (OR 4.68), hyperlipidemia (OR 5.86), obesity (OR 2.97), and increasing age (OR 1.07 per year) were independently associated with occult carcinoma. A predictive model estimated individual risk ranging from 5.6% to 95.0% according to accumulation of risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Older age, biopsy method, obesity, hyperlipidemia, and bleeding presentation are independently associated with an occult endometrial carcinoma in women with atypical endometrial hyperplasia. The proposed model may support preoperative risk stratification and counseling, but\u00a0it requires external validation before clinical use, including decisions regarding sentinel lymph node biopsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-026-08329-y","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:50:49Z","timestamp":1769709049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk factors and predictive modeling for occult endometrial cancer in women with atypical hyperplasia: a retrospective study"],"prefix":"10.1007","volume":"313","author":[{"given":"Keren","family":"Wolff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Gumin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raneen Abu","family":"Shqara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishalom","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inshirah","family":"Sgayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2169-2977","authenticated-orcid":false,"given":"Ala","family":"Aiob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"6","key":"8329_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"8329_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jnci\/djx214","volume":"110","author":"J Lortet-Tieulent","year":"2018","unstructured":"Lortet-Tieulent J, Ferlay J, Bray F, Jemal A (2018) International patterns and trends in endometrial cancer incidence, 1978\u20132013. J Natl Cancer Inst 110(4):354\u2013361. https:\/\/doi.org\/10.1093\/jnci\/djx214","journal-title":"J Natl Cancer Inst"},{"issue":"100231","key":"8329_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, DE Abu-Rustum N (2016) Endometrial cancer. Lancet 387(100231):1094\u20131108","journal-title":"Lancet"},{"issue":"2","key":"8329_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/humupd\/dmw042","volume":"23","author":"PA Sanderson","year":"2017","unstructured":"Sanderson PA, Critchley HOD, Williams ARW, Arends MJ, Saunders PTK (2017) New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update 23(2):232\u2013254. https:\/\/doi.org\/10.1093\/humupd\/dmw042","journal-title":"Hum Reprod Update"},{"key":"8329_CR5","doi-asserted-by":"publisher","first-page":"678.e1","DOI":"10.1016\/j.ajog.2009.02.032","volume":"200","author":"SD Reed","year":"2009","unstructured":"Reed SD, Newton KM, Clinton WL et al (2009) Incidence of endometrial hyperplasia. Am J Obstet Gynecol 200:678.e1-678.e6","journal-title":"Am J Obstet Gynecol"},{"key":"8329_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejogrb.2018.01.026","volume":"222","author":"ML Iversen","year":"2018","unstructured":"Iversen ML, Dueholm M (2018) Complex non atypical hyperplasia and the subsequent risk of carcinoma, atypia and hysterectomy during the following 9\u201314 years. Eur J Obstet Gynecol Reprod Biol 222:171\u2013175","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"8329_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/uog.20421","volume":"55","author":"O Rotenberg","year":"2020","unstructured":"Rotenberg O, Fridman D, Doulaveris G et al (2020) Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling. Ultrasound Obstet Gynecol 55:546\u2013551. https:\/\/doi.org\/10.1002\/uog.20421","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8329_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/his.13776","volume":"74","author":"A Travaglino","year":"2019","unstructured":"Travaglino A, Raffone A, Saccone G et al (2019) Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria. Histopathology 74:676\u2013687","journal-title":"Histopathology"},{"issue":"5","key":"8329_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jmig.2016.03.017","volume":"23","author":"N Bourdel","year":"2016","unstructured":"Bourdel N, Chauvet P, Tognazza E, Pereira B, Botchorishvili R (2016) Sampling in atypical endometrial hyperplasia: which method results in the lowest underestimation of endometrial cancer? A systematic review and meta-analysis. J Minim Invasive Gynecol 23(5):692\u2013701. https:\/\/doi.org\/10.1016\/j.jmig.2016.03.017","journal-title":"J Minim Invasive Gynecol"},{"issue":"4","key":"8329_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/cncr.21650","volume":"106","author":"CL Trimble","year":"2006","unstructured":"Trimble CL, Kauderer J, Zaino R et al (2006) Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer 106(4):812\u2013819. https:\/\/doi.org\/10.1002\/cncr.21650","journal-title":"Cancer"},{"issue":"10","key":"8329_CR11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S1701-2163(16)32969-3","volume":"30","author":"KC Giede","year":"2008","unstructured":"Giede KC, Yen TW, Chibbar R, Pierson RA (2008) Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia. J Obstet Gynaecol Can 30(10):896\u2013901","journal-title":"J Obstet Gynaecol Can"},{"key":"8329_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/PAS.0b013e31825dd4ff","volume":"36","author":"E Rakha","year":"2012","unstructured":"Rakha E, Wong SC, Soomro I et al (2012) Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature. Am J Surg Pathol 36:1683\u20131690","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"8329_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/ijgc-2023-004936","volume":"34","author":"S Vieira-Serna","year":"2024","unstructured":"Vieira-Serna S, Peralta J, Viveros-Carre\u00f1o D, Rodriguez J, Feliciano-Alfonso JE, Pareja R (2024) Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis. Int J Gynecol Cancer 34(1):66\u201372. https:\/\/doi.org\/10.1136\/ijgc-2023-004936","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"8329_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232231","volume":"15","author":"MT Doherty","year":"2020","unstructured":"Doherty MT, Sanni OB, Coleman HG, Cardwell CR, McCluggage WG, Quinn D, Wylie J, McMenamin \u00daC (2020) Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: a\u00a0systematic review and meta-analysis. PLoS ONE 15(4):e0232231. https:\/\/doi.org\/10.1371\/journal.pone.0232231","journal-title":"PLoS ONE"},{"issue":"1","key":"8329_CR15","doi-asserted-by":"publisher","first-page":"60.e1","DOI":"10.1016\/j.ajog.2019.08.002","volume":"222","author":"MH Vetter","year":"2020","unstructured":"Vetter MH, Smith B, Benedict J, Hade EM, Bixel K, Copeland LJ, Cohn DE, Fowler JM, O\u2019Malley D, Salani R, Backes FJ (2020) Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Am J Obstet Gynecol 222(1):60.e1-60.e7. https:\/\/doi.org\/10.1016\/j.ajog.2019.08.002","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8329_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ygyno.2015.07.108","volume":"139","author":"K Matsuo","year":"2015","unstructured":"Matsuo K, Ramzan AA, Gualtieri MR et al (2015) Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol 139(2):261\u2013267. https:\/\/doi.org\/10.1016\/j.ygyno.2015.07.108","journal-title":"Gynecol Oncol"},{"issue":"1","key":"8329_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14312-8","volume":"25","author":"N\u00c7 \u00c7altek","year":"2025","unstructured":"\u00c7altek N\u00c7, \u00c7altek H\u00d6, Yassa M, G\u00fcner G, Yaman \u0130, Y\u00fcksel \u0130T (2025) Preoperative predictors of endometrial carcinoma in patients undergoing hysterectomy for endometrial intraepithelial neoplasia. BMC Cancer 25(1):883. https:\/\/doi.org\/10.1186\/s12885-025-14312-8","journal-title":"BMC Cancer"},{"issue":"2","key":"8329_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/ajo.13300","volume":"61","author":"VA Rajadurai","year":"2021","unstructured":"Rajadurai VA, Chivers P, Ayres C et al (2021) Predictors of endometrial carcinoma in patients with atypical endometrial hyperplasia at a tertiary gynaecological cancer centre in Western Australia. Aust N Z J Obstet Gynaecol 61(2):275\u2013283. https:\/\/doi.org\/10.1111\/ajo.13300","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"8329_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/annonc\/mdq464","volume":"22","author":"V Rosato","year":"2011","unstructured":"Rosato V, Zucchetto A, Bosetti C et al (2011) Metabolic syndrome and endometrial cancer risk. Ann Oncol 22(4):884\u2013889. https:\/\/doi.org\/10.1093\/annonc\/mdq464","journal-title":"Ann Oncol"},{"key":"8329_CR20","doi-asserted-by":"publisher","unstructured":"Trabert B, Wentzensen N, Felix AS, Yang HP, Sherman ME, Brinton LA (2015) Metabolic syndrome and risk of endometrial cancer in the United States: a study in the SEER-medicare linked database. Cancer Epidemiol Biomarkers Prev 24(1):261\u2013267. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0923","DOI":"10.1158\/1055-9965.EPI-14-0923"},{"issue":"5","key":"8329_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050914","volume":"16","author":"L Giannella","year":"2024","unstructured":"Giannella L, Grelloni C, Bernardi M et al (2024) Atypical endometrial hyperplasia and concurrent cancer: a comprehensive overview on a challenging clinical condition. Cancers (Basel) 16(5):914. https:\/\/doi.org\/10.3390\/cancers16050914","journal-title":"Cancers (Basel)"},{"issue":"6","key":"8329_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-072124","volume":"13","author":"NA Sakna","year":"2023","unstructured":"Sakna NA, Elgendi M, Salama MH, Zeinhom A, Labib S, Nabhan AF (2023) Diagnostic accuracy of endometrial sampling tests for detecting endometrial cancer: a systematic review and meta-analysis. BMJ Open 13(6):e072124. https:\/\/doi.org\/10.1136\/bmjopen-2023-072124","journal-title":"BMJ Open"},{"issue":"5","key":"8329_CR23","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00404-012-2438-8","volume":"286","author":"F Demirkiran","year":"2012","unstructured":"Demirkiran F, Yavuz E, Erenel H, Bese T, Arvas M, Sanioglu C (2012) Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatation and curettage (D&C). Arch Gynecol Obstet 286(5):1277\u20131282. https:\/\/doi.org\/10.1007\/s00404-012-2438-8","journal-title":"Arch Gynecol Obstet"},{"key":"8329_CR24","doi-asserted-by":"publisher","unstructured":"Management of endometrial intraepithelial neoplasia or atypical endometrial hyperplasia: ACOG Clinical Consensus No. 5 (2023) Obstet Gynecol 142(3):735\u2013744. https:\/\/doi.org\/10.1097\/AOG.0000000000005297","DOI":"10.1097\/AOG.0000000000005297"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08329-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:50:50Z","timestamp":1769709050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08329-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8329"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08329-y","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Helsinki Committee of Galilee Medical Center (IRB number: NHR-0070-24). Due to the study\u2019s retrospective nature, informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Participant consent was unnecessary due to the study\u2019s retrospective design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"67"}}